Pancreatic Elastase Testing Market Size

Pancreatic Elastase Testing Market size was over USD 17.55 billion in 2024 and is projected to reach USD 46.59 billion by 2037, witnessing around 7.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of pancreatic elastase testing is assessed at USD 18.71 billion.

Pancreatic elastase test, also known as, fecal elastase, is used to test the amount of elastase produced in the body. Elastase is an enzyme secreted by the pancreas to break down fats, proteins, and carbohydrates. The growth of the market can be attributed to the increasing prevalence of pancreatic insufficiency, chronic pancreatitis, and others. According to a report published by National Center for Biotechnology Information and StatPearls Publishing, chronic pancreatitis occurs in 42 to 73 individuals per 100,000 of the population in the United States, while the prevalence in Japan, China, and India is around 36 to 125 per 100,000 individuals, as of 2021. Moreover, improvement in the diagnostic technologies, penetration of AI in medical diagnostics, and rising awareness amongst people regarding tests and diagnosis are anticipated to boost the market growth. Furthermore, the increasing healthcare expenditure across the globe, is forecasted to encourage the growth of the market.